Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Leishmaniasis, as a tropical and subtropical disease, is endemic in more than 90 countries around the world. Today, cutaneous leishmaniasis (CL) that affects more than 1.5 million people per year lacks a definitive treatment approach. Imatinib is an anticancer drug that inhibits the abnormal functio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:AIMS Microbiol
Autori principali: Moslehi, Mohsen, Namdar, Fatemeh, Esmaeilifallah, Mahsa, Iraji, Fariba, Vakili, Bahareh, Sokhanvari, Fatemeh, Hosseini, Seyed-Mohsen, Khamesipour, Faham, Sebghatollahi, Zahra, Hejazi, Sayed-Hossein
Natura: Artigo
Lingua:Inglês
Pubblicazione: AIMS Press 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7326727/
https://ncbi.nlm.nih.gov/pubmed/32617447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3934/microbiol.2020010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi